Poster Abstract Session:
231. Clostridium difficile: Outcomes, Testing, Prevention
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

.

Tracks: Epidemiology and Infection Control, Adult ID

Presentations:
2079
Hospital readmissions related to Clostridium difficile infection
Abhishek Deshpande, MD, PhD ; Chaitanya Pant, MD ; Mojtaba Olyaee, MD ; Curtis J. Donskey, MD
2080
Infrequent Skin Contamination with Clostridium difficile Spores Among Oncology Patients on Units with a High Incidence of C. difficile Colonization
Shela Sridhar, MD ; Curtis J. Donskey, MD ; Nathan Ledeboer, PhD, D(ABMM) ; Nicholas Yunker, - ; Tami Mackey, MT(ASCP) ; Mary Beth Graham, MD, FIDSA ; April Vanderslik, RN, BSN, CIC ; Laura Michaelis, MD ; Parameswaran Hari, MD ; L. Silvia Munoz-Price, MD, PhD
2081
Tests for Inflammation (Stool and Blood) and Stool Spore Density Correlate Better with C. difficile Infection (CDI) (tcdB and Toxin Positive Samples) than the Number of Stools per Day
James Boone, MS ; Becky Smith, MD ; Robert Carman, PhD ; David Persing, MD, PhD ; Lance Peterson, MD, FIDSA, FSHEA
Posters
  • IDweek2016 poster-JB-10 12 16LP.pdf (468.8 kB)
    • 2082
    Real-Time Clinical Data Tracking Enables Enforcement of Diarrhea and Absence of Laxatives in Hospitalized Patients Undergoing Clostridium difficile Testing
    Cynthia Truong, BS ; Lee Schroeder, MD, PhD ; Marisa Holubar, MD, MS ; John Shepard, BA, MBA, MHA ; Alexandra Madison, BS, BA, MPH ; Lucy Tompkins, MD, PhD, FSHEA, FIDSA ; Neil Shah, MD ; Niaz Banaei, MD
    2083
    Implication of Clostridium difficile Strain Typing in Recurrent C. difficile Infection
    Donna Schora, MT(ASCP) ; Sanchita Das, MD ; Becky Smith, MD ; James Boone, MS ; Robert Carman, PhD ; Lance Peterson, MD, FIDSA, FSHEA
    Posters
  • ID Week 2016. Schora. Implication of Cdif Strain Typing on Recurrent CDI.pdf (225.9 kB)
    • 2084
    Role of asymptomatic Clostridium difficile carriers in intra-hospital transmission and healthcare-associated Clostridium difficile infection: a transmission modeling analysis
    Justin O'hagan, ScD ; Lawrence Mcdonald, MD ; John Jernigan, MD, MS ; Rachel Slayton, PhD, MPH
    2085
    The Interplay Between Acute and Long-Term Care C. difficile Incidence in the United States Veterans Health Administration: A Retrospective Cohort Study of 169 Facilities
    Kevin Brown, PhD ; Matthew Samore, MD, FSHEA
    2086
    Effect of an Electronic Hard-Stop Intervention to Prevent Repeat Clostridium difficile Toxin Testing on Test Utilization and Clinical Outcomes
    Jennie H. Kwon, DO, MSCI ; Kimberly Reske, MPH ; Tiffany Hink, BS ; Ronald Jackups Jr., MD ; Carey-Ann D. Burnham, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA
    2087
    Healthcare Resource Utilization and Costs of Recurrent CDI 
    Omneya Mohamed, PhD
    Posters
  • mohamomn_192355-0001-ID-Week_CDI_Poster_v1.05.pdf (231.8 kB)
    • 2088
    The Role of Surface Adhesins in Clostridium difficile Virulence and Biofilm Formation: Comparison between a Non-Epidemic and an Epidemic Strain 
    Soza Baban, PhD
    2089
    Detection and Infection Prevention Differs between Community Onset (CO) and Hospital Onset (HO) Clostridium difficile Cases
    J Bradford Bertumen, MD ; Christopher W Woods, MD, MPH, FIDSA ; Susan Wilkins, BS, MDiv ; Lawrence Park, PhD
    Posters
  • ID Week poster (2).pdf (429.2 kB)
    • 2090
    Performance of Published Clostridium difficile Severity Scoring Systems in an External Cohort
    Daniel Mcclung, MD ; Krishna Rao, MD, MS ; Peter D. R. Higgins, MD, PhD ; Vincent B. Young, MD, PhD, FIDSA
    Posters
  • IDWEEK poster CDI Severity Scores Validation.pdf (915.4 kB)
    • 2091
    The Impact of Laxative Use on Hospital Onset Clostridium Difficile Diarrhea
    Saritha Gomadam, D.O ; Moises Huaman, MD, MSc ; Tigre Suder, RN, BSN ; Derek Forster, MD
    2092
    Transfer of Bacteriophage MS2 versus Clostridium difficile Spores to Environmental Surfaces during Simulations of Patient Care
    Heba Alhmidi, MD ; Sreelatha Koganti, MD ; Myreen Tomas, MD ; Jennifer L. Cadnum, BS ; Annette Jencson, BSMT(ASCP)SM, CIC ; Thriveen Mana, M.S., MBA ; Curtis J. Donskey, MD
    Posters
  • Microbial Transfer to Environmental Surfaces after Simulations of Patient Care.pdf (503.2 kB)
    • 2093
    Estimating local attributable cost of Clostridium difficile infection using electronic medical record data
    Theodore Pak, AB ; Kieran Chacko, BA, BS ; Timothy O'donnell, BSc ; Shirish Huprikar, MD ; Harm Van Bakel, PhD ; Andrew Kasarskis, PhD ; Erick Scott, MD, MHS
    2094
    Outcomes of Recurrent Clostridium difficile Infection among Patients Diagnosed in the Hospital and Community Settings
    Jennifer Kuntz, PhD ; Xiuhai Yang, MS
    2095
    TITLE: Reduction of Clostridium difficile (C diff) cases using a targeted assessment for prevention (TAP) strategy in the Department of Veterans Affairs (VA) healthcare system.
    Gary Roselle, MD, FIDSA ; Stephen Kralovic, MD, MPH, FSHEA ; Loretta Simbartl, MS ; Martin Evans, MD, FIDSA, FSHEA
    2096
    Clostridium Difficile, Evaluation of Testing Practices, non C. Difficile Antibiotic Use and Implications for the Clinical Practice
    Victor Cepeda, MD ; Prakash Shrestha, MD ; Kelly Echevarria, Pharm.D,.BCPS, AQ-ID ; Courtney Ortiz, Pharm.D., BCPS ; Hilda Ben, BSN, RN, CIC ; Jose Cadena, MD/ID
    Posters
  • final-poster-idsa-cdiff-2016.png (1.1 MB)
    • 2097
    Reducing Unnecessary Clostridium difficile Testing in a Community Teaching Hospital
    Uri Goldberg, MD ; Alok Gupta, MD ; Virginie Auguste, MD ; Jorge Donado, MD ; Vincent Peyko, Pharm.D ; Angela Belfer, RN ; Pwint Htwe, MD ; Rajat Mukherji, MD
    2098
    Initiation of a Performance Review Committee (PRC) with Multi-Disciplinary Healthcare Team Members and the Impact on Hospital-Acquired Clostridium difficile Infection (CDI)
    Kristie Zappas, PharmD, BCPS (AQ-ID) ; James Mcclelland, MD ; Kerry Schwartz, MD, FACC, FACP ; Jason Price, MBA, MSN, RN ; Cathy Stankiewicz, MSN, RN, CPHQ ; Alba Cruz-Betancourt, MSN, RN, CCNS ; Hermanda Milton, MSN/Ed ; Patrice Berwager, MSN, RN, CEN ; Kurry Lewis, RN ; Julie Hess, MT(ASCP) ; Brian Jones, BS
    2099
    Impact of the BioFire® FilmArray Gastrointestinal Panel in Children Hospitalized for Acute Gastroenteritis
    Jennifer Dien Bard, Ph.D ; Ara Festekjian, MD ; Chris Stockmann, PhD, MSc ; Daniel Cohen, MD ; Amy Leber, PhD ; Judy Daly, PhD ; Jami Jackson, DO ; Rangaraj Selvarangan, PhD ; Neena Kanwar, PhD ; Susan Duffy, MD ; Kristen Holmberg, PhD ; Kevin Bourzac, PhD ; Kimberle C. Chapin, MD ; Andrew Pavia, MD, FIDSA, FSHEA, FPIDS ; Jeffery Bender, MD
    Posters
  • BioFire IDWeek poster.pdf (386.6 kB)

    • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.